Journal for ImmunoTherapy of Cancer (Nov 2020)
862 Targeting PSGL-1, a novel macrophage checkpoint, repolarizes suppressive macrophages, induces an inflammatory tumor microenvironment, and suppresses tumor growth
Abstract
No abstracts available.
Journal for ImmunoTherapy of Cancer (Nov 2020)